Mankind, established in 1995, is India’s leading pharmaceutical company by number of prescriptions, and 5th in the market by domestic sales. Mankind produces branded generic drugs sold throughout India, with a uniquely deep reach in rural and semi-urban markets.
Mankind’s loyal sales force – the largest in India with 10,000 representatives – brings a robust offering of quality and competitively priced products to hard-to-reach areas. Prescription products for acute therapies comprise the majority of Mankind’s sales. The company is also a leading player in nutritional supplements and gynecological products.
India has a fast growing pharmaceutical industry with very favorable demographics, increased awareness and acceptance of modern medicines, rising healthcare services penetration, and growing spending power. For the five years leading up to CIPEF VI’s investment in 2015, Mankind was growing at approximately double the domestic pharma industry growth rate. We believe that Mankind’s solid management team, highly driven salesforce, and strong culture will set the stage for continued growth.
